HIF1A and metabolic dysfunction-associated steatotic liver disease: The activation of HIF-1α in the liver and hepatocytes can promote lipid accumulation and liver damage to accelerate disease progression in a methionine–choline-deficient diet-induced NAFLD mouse (19).